Cargando…
Development of an inducible anti-VEGF rAAV gene therapy strategy for the treatment of wet AMD
Vascular endothelial growth factor (VEGF) is a key mediator in the development and progression of choroidal neovascularization (CNV) in patients with wet age-related macular degeneration (AMD). As a consequence, current treatment strategies typically focus on the administration of anti-VEGF agents,...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079038/ https://www.ncbi.nlm.nih.gov/pubmed/30082848 http://dx.doi.org/10.1038/s41598-018-29726-7 |